Arcoris bio, a Swiss company specializing in life science research tools and in vitro diagnostics, has today revealed a distribution partnership with Europa Biosite, a prominent distributor of life science research products and services.
Via this collaboration, Europa Biosite will distribute arcoris bio’s recently launched immunoMUSE® kits in various European markets and throughout North America.
Using immunoMUSE®, researchers can develop custom multiplex immunofluorescence panels with their chosen antibodies, merging high sensitivity with flexibility and simplicity.
arcoris bio’s MUSE® technology facilitates the concurrent identification of various biomarkers with outstanding sensitivity and streamlined procedures.
MUSE® enhances the identification of low-abundance targets in a single sample and facilitates increased throughput, making it ideally suited to promote advancements in digital pathology and translational research.
“Europa Biosite is an ideal partner for arcoris bio as we continue to expand the reach of our MUSE® platform across Europe and North America. immunoMUSE® gives researchers the freedom to build multiplex immunofluorescence panels with the antibodies they already trust, while benefiting from the exceptional sensitivity of our proprietary signal amplification technology," says Matyas Vegh, CEO, arcoris bio.
Also Read: JLR Ties Up with DCS for Europe EV Charging
"By combining our innovation with Europa Biosite’s extensive commercial and scientific network, we can help more researchers unlock valuable biological insights and advance the next generation of spatial biology and digital pathology applications,” adds Matyas.
Also Read: Marqeta Expands Partnership with Expensify
Sebastian Buchert, Group Product Director at Europa Biosite says, “We are excited to add immunoMUSE® to our portfolio of innovative life science solutions. The technology addresses a growing demand for highly sensitive and flexible multiplex immunofluorescence workflows. We believe immunoMUSE® offers researchers a unique opportunity to leverage their existing antibody expertise while achieving superior analytical performance, and we look forward to making this solution available to our customers across Europe and North America.”
Also Read: Dutch e-Smart Avia Eyes Europe’s First Electric Cargo Airline
Compared to conventional staining approaches, immunoMUSE® improves signal-to-noise ratios, enabling more reliable detection of low-abundance biomarkers and increasing overall assay sensitivity.